Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a456d7d7ec222a83

Jump to content

Ovoferrin

From Wikipedia, the free encyclopedia

Ovoferrin was a dietary supplement originally produced in the United States by A.C. Barnes Company[1] of Philadelphia, Pennsylvania[2] and later by Zonite Products Corporation, which acquired A.C. Barnes Company in 1929.[1] The product grossed approximately $400,000 annually in 1929.[2] Both Ovoferrin and Argyrol continued to be exclusively manufactured by A.C. Barnes Company, which became a subsidiary of Zonite Products Corporation. On January 2, 1946 Ovoferrin and Argyrol were assigned to Erwin, Wasey & Company, a New York based advertising agency.[3]

Chemical composition

[edit]

Ovoferrin was advertised as a supplement for iron and Vitamin B.[4]

Ovoferrin's manufacturer described its makeup as being neutral in reaction. A tablespoon was stated to be equivalent to a single grain of elementary iron. When potassium ferrocyanide is added to Ovorferrin no change is observed. However the addition of hydrochloric acid to Ovoferrin produces a well-known color and precipitate of Prussian blue. This indicates that hydrochloric acid changes Ovoferrin, producing an inorganic iron.[5]

References

[edit]
  1. 1 2 Inquiring Investor, Wall Street Journal, November 29, 1930, pg. 11.
  2. 1 2 Zonite Capital Plan Approved, Wall Street Journal, July 12, 1929, pg. 9.
  3. ↑ Advertising News and Notes, New York Times, October 10, 1945, pg. 25.
  4. ↑ "Ovoferrin". National Museum of American History. Retrieved 2019-09-01.
  5. ↑ American Druggist and Pharmaceutical Record, American Druggist Publishing Company, 1904, pg. 171.